Arcellx (ACLX)

• Market cap: $4.93B
• 1 day: -3.81%
• 5 days: -0.41%
• 1 month: 14.87%
• 3 months: 25.67%
• 6 months: 46.4%
• Year to date: 12.83%
• 1 year: -4.46%
• 5 years: 428.87%
• 10 years: 428.87%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163